Scott Sullivan, MD
Retina Specialist · Germantown, TNNPI 1689100471
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,947 of the $4,705 with a category attached, or 62.6%. Kyowa Kirin, Inc. accounts for 68.3% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2024 at $3,289 and has fallen 82.2% since, to $587 in 2025.
Across 51 payments — averaging $92.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kyowa Kirin, Inc.$3K
- Regeneron Healthcare Solutions, Inc.$246
- Mallinckrodt Hospital Products Inc.$221
- Apellis Pharmaceuticals, Inc.$197
- Ocular Therapeutix, Inc.$147
- AbbVie$136
- plus $546 from 9 others
What the payments were for
- Travel & lodging$2,94763%
- Food & beverage$1,66135%
- Education$982%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kyowa Kirin, Inc. | 7 | $3,212 |
| Regeneron Healthcare Solutions, Inc. | 8 | $246 |
| Mallinckrodt Hospital Products Inc. | 7 | $221 |
| Apellis Pharmaceuticals, Inc. | 6 | $197 |
| Ocular Therapeutix, Inc. | 1 | $147 |
| AbbVie | 7 | $136 |
| Eyepoint US, Inc. | 1 | $135 |
| Sun Pharmaceutical Industries Inc. | 1 | $112 |
| ANI Pharmaceuticals, Inc. | 4 | $107 |
| Genentech USA, Inc. | 3 | $58 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $54 |
| Coherus Oncology, Inc. | 2 | $32 |
| Alcon | 1 | $17 |
| Astellas Pharma US Inc | 1 | $16 |
| Spark Therapeutics, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,705 in reported general payments places this provider in the 65th percentile of 58 retina specialist providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 147 | $6,666 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 180 | $2,182 |
| Latanoprost | 284 | $1,862 |
| Ketorolac Tromethamine | 38 | $1,422 |
| Brimonidine Tartrate | 111 | $1,236 |
| Timolol Maleate | 53 | $1,027 |
| Tobramycin | 69 | $416 |
| Dorzolamide Hcl | 18 | $271 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Germantown
- Steve CharlesGermantown$5.8M
- Salar RafieetaryGermantown$37K
- Stephen HuddlestonGermantown$31K
- David FingerhutGermantown$4K
- Kyle VinsonGermantown$2K
- Wesley GilletteGermantown$1K
- Carl AwhNashville$1.3M
- Peter SonkinNashville$949K
- Brandon BusbeeNashville$566K
- Eric SchneiderNashville$134K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.